These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9892617)

  • 61. Differential contributions of APC subsets to T cell activation in nonobese diabetic mice.
    Marleau AM; Summers KL; Singh B
    J Immunol; 2008 Apr; 180(8):5235-49. PubMed ID: 18390704
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Cellular immune dysfunction in the NOD mouse: suppression of concanavalin A-induced responses in spleen cells by activated macrophages].
    Kawase Y; Yokono K; Nagata M; Hatamori N; Akiyama H; Sakamoto T; Yonezawa K; Yaso S; Shii K; Baba S
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):674-85. PubMed ID: 2583313
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice.
    Bour-Jordan H; Thompson HL; Bluestone JA
    J Immunol; 2005 Nov; 175(9):5649-55. PubMed ID: 16237054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Autoimmunity to both proinsulin and IGRP is required for diabetes in nonobese diabetic 8.3 TCR transgenic mice.
    Krishnamurthy B; Mariana L; Gellert SA; Colman PG; Harrison LC; Lew AM; Santamaria P; Thomas HE; Kay TW
    J Immunol; 2008 Apr; 180(7):4458-64. PubMed ID: 18354167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Splenic macrophages from the NOD mouse are defective in the ability to present antigen.
    Piganelli JD; Martin T; Haskins K
    Diabetes; 1998 Aug; 47(8):1212-8. PubMed ID: 9703319
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intervention in autoimmune diabetes by targeting the gut immune system.
    Bellmann K; Kolb H; Hartmann B; Rothe H; Rowsell P; Rastegar S; Burghardt K; Scott FW
    Int J Immunopharmacol; 1997; 19(9-10):573-7. PubMed ID: 9637357
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice.
    Rothe H; Burkart V; Faust A; Kolb H
    Diabetologia; 1996 Jan; 39(1):119-22. PubMed ID: 8720612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Autoimmune destruction of pancreatic beta cells.
    Yoon JW; Jun HS
    Am J Ther; 2005; 12(6):580-91. PubMed ID: 16280652
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Initial role of macrophage in the development of anti-beta-cell cellular autoimmunity in multiple low-dose streptozotocin-induced diabetes in mice.
    Ihm SH; Lee KU; Rhee BD; Min HK
    Diabetes Res Clin Pract; 1990 Oct; 10(2):123-6. PubMed ID: 2175696
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Macrophages and β-cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes.
    Diana J; Lehuen A
    EMBO Mol Med; 2014 Aug; 6(8):1090-104. PubMed ID: 24968718
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Essential contribution of macrophages to islet cell destruction in vivo and in vitro.
    Kolb H; Burkart V; Appels B; Hanenberg H; Kantwerk-Funke G; Kiesel U; Funda J; Schraermeyer U; Kolb-Bachofen V
    J Autoimmun; 1990 Apr; 3 Suppl 1():117-20. PubMed ID: 2140261
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice.
    Trivedi PM; Fynch S; Kennedy LM; Chee J; Krishnamurthy B; O'Reilly LA; Strasser A; Kay TWH; Thomas HE
    Cell Death Discov; 2019; 5():136. PubMed ID: 31552143
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mechanisms of cytokine-mediated localized immunoprotection.
    Sarvetnick N
    J Exp Med; 1996 Nov; 184(5):1597-600. PubMed ID: 8920849
    [No Abstract]   [Full Text] [Related]  

  • 74. The proinflammatory effects of macrophage-derived NADPH oxidase function in autoimmune diabetes.
    Feduska JM; Tse HM
    Free Radic Biol Med; 2018 Sep; 125():81-89. PubMed ID: 29723665
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comment on: Meagher et al. Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism. Diabetes 2010;59:2862-2871.
    Vendrame F; Dotta F
    Diabetes; 2011 Feb; 60(2):e12; author reply e13. PubMed ID: 21270245
    [No Abstract]   [Full Text] [Related]  

  • 76. The beta cell in autoimmune diabetes: many mechanisms and pathways of loss.
    Kay TW; Thomas HE; Harrison LC; Allison J
    Trends Endocrinol Metab; 2000; 11(1):11-5. PubMed ID: 10652500
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.
    Burg AR; Tse HM
    Antioxid Redox Signal; 2018 Nov; 29(14):1373-1398. PubMed ID: 29037052
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes.
    Murphy WJ
    J Clin Invest; 2000 Sep; 106(6):745-7. PubMed ID: 10995784
    [No Abstract]   [Full Text] [Related]  

  • 79. Emetine Di-HCl Attenuates Type 1 Diabetes Mellitus in Mice.
    Hudson LK; Dancho ME; Li J; Bruchfeld JB; Ragab AA; He MM; Bragg M; Lenaghan D; Quinn MD; Fritz JR; Tanzi MV; Silverman HA; Hanes WM; Levine YA; Pavlov VA; Olofsson PS; Roth J; Al-Abed Y; Andersson U; Tracey KJ; Chavan SS
    Mol Med; 2016 Oct; 22():585-596. PubMed ID: 27341452
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epigenetic modulation of selected immune response genes and altered functions of T lymphocytes and macrophages collectively contribute to autoimmune diabetes protection.
    Jayaraman A; Arianas M; Jayaraman S
    BBA Adv; 2021; 1():100031. PubMed ID: 37082012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.